The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

MASH is an advanced stage of metabolic dysfunction-associated steatotic liver disease (MASLD), which an estimated 25% of American adults have. However, only 20% of those progress into MASH.

Wegovy treated a serious form of liver disease in a major clinical trial The Phase 3 clinical trial found that Wegovy reduced inflammation and scarring in people with metabolic dysfunction ...

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...